DOI: 10.1055/s-00000054

Pharmacopsychiatry

eFirst

Publication Date: 04 June 2025

Original Paper

Wan Mohd Johari, Wan F. H.; Abang Ma’mon, Dayang F.; Wahab, Izyan A; Bahruddin, Nurul A.; Shamsuddin, Noorasyikin: Instruments Assessing Medication Literacy in Psychiatric Patients and the Caregivers: A Systematic Review
Supplementary Material

Publication Date: 02 June 2025

Original Paper

Dormegny-Jeanjean, Ludovic C.; Lenoir, Suzie; Humbert, Ilia; Mainberger, Olivier A. E.; Lozere, Coraline; Meyer, Camille; Geny, Bernard; Michel, Bruno; Foucher, Jack R.; de Crespin de Billy, Clément: Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses
Supplementary Material

Original Paper

Xie, Jiangchuan; Ma, Pan; Pan, Xinmei; Cao, Liya; Liu, Ruixiang; Xiong, Lirong; Wang, Hongqian; Zhang, Xin; Xie, Linli; Chen, Yongchuan: Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment
Supplementary Material

Publication Date: 12 May 2025

Review

Monteith, Scott; Glenn, Tasha; Geddes, John R.; Whybrow, Peter C.; Achtyes, Eric D.; Bauer, Rita; Bauer, Michael: Patient and Physician Exposure to Artificial Intelligence Hype

Publication Date: 17 April 2025

Original Paper

Kuzo, Nazar; Piras, Marianna; Lutz, Ulrich C.; Haen, Ekkehard; Eap, Chin B.; Hiemke, Christoph; Paulzen, Michael; Schoretsanitis, Georgios: Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis
Supplementary Material

Original Paper

Swieczkowski, Damian; Kwaśny, Aleksander; Pruc, Michal; Gaca, Zuzanna; Szarpak, Lukasz; Cubała, Wiesław J.: Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis
Supplementary Material

Publication Date: 14 April 2025

Review

Liu, Tingting; Shi, Fuqiang; Guo, Zhihua; Li, Hongwu; Qin, Di: Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder

Publication Date: 27 March 2025

Letter to the Editor

Abdel-Hamid, Mona; Lyons, Naomi; Specka, Michael; Bartels, Claudia; Belz, Michael; Hessmann, Philipp; Schecke, Henrike; Zwarg, Thomas; Scherbaum, Norbert: Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD

Publication Date: 25 February 2025

Original Paper

Tavakoli, Emytis; Xiang, Angela; Husain, Mohamed I.; Blumberger, Daniel M.; Kloiber, Stefan; Mueller, Daniel J.; Ortiz, Abigail; Perivolaris, Athina; Mulsant, Benoit H.: Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study
Supplementary Material

Publication Date: 29 January 2025

Review

Kishi, Taro; Citrome, Leslie; Sakuma, Kenji; Hamanaka, Shun; Nishii, Yasufumi; Hatano, Masakazu; Furukawa, Osamu; Saito, Youichi; Iwata, Nakao: Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes
Supplementary Material

Publication Date: 20 December 2024

Original Paper

Chen, Mu-Hong; Su, Tung-Ping; Lin, Wei-Chen; Li, Cheng-Ta; Wu, Hui-Ju; Tsai, Shih-Jen; Bai, Ya-Mei; Mao, Wei-Chung; Tu, Pei-Chi: Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation

Publication Date: 17 December 2024

Original Paper

Hsu, Tien-Wei; Tsai, Shih-Jen; Chen, Tzeng-Ji; Chen, Mu-Hong; Liang, Chih-Sung: Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study
Supplementary Material

Publication Date: 11 November 2024

Original Paper

Parabiaghi, Alberto; Galbussera, Alessia A.; D’Avanzo, Barbara; Tettamanti, Mauro; Fortino, Ida; Barbato, Angelo: 2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation
Supplementary Material